ST elevation myocardial infarction glycoprotein IIbIIIa inhibition: Revision history

8 November 2016

• curprev 19:1619:16, 8 November 2016‎ Luke Rusowicz-Orazem talk contribs‎ 83,823 bytes −13‎ →‎Other Antiplatelet Agents Including Aspirin and Thienopyridines*LUKELUKELUKE
• curprev 19:1519:15, 8 November 2016‎ Haleigh Williams talk contribs‎ 83,836 bytes +13‎ No edit summary

30 January 2013

• curprev 15:0015:00, 30 January 2013‎ Raviteja Reddy Guddeti talk contribs‎ 83,823 bytes 0‎ /* Intravenous Antiplatelet Therapy in patients of ST-Elevation Myocardial Infarction (STEMI) (DO NOT EDIT){{cite journal |author=O'Gara PT, Kushner FG, Ascheim DD, et al. |title=2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardia...
• curprev 14:5814:58, 30 January 2013‎ Raviteja Reddy Guddeti talk contribs‎ 83,823 bytes 0‎ →‎Facilitated PCI trials using Eptifibatide
• curprev 14:5714:57, 30 January 2013‎ Raviteja Reddy Guddeti talk contribs‎ 83,823 bytes 0‎ →‎Facilitated PCI trials using Abciximab
• curprev 14:5714:57, 30 January 2013‎ Raviteja Reddy Guddeti talk contribs‎ 83,823 bytes 0‎ →‎Facilitated PCI trials using Tirofiban
• curprev 14:5014:50, 30 January 2013‎ Raviteja Reddy Guddeti talk contribs‎ 83,823 bytes +12‎ →‎Facilitated PCI trials using Tirofiban
• curprev 14:4714:47, 30 January 2013‎ Raviteja Reddy Guddeti talk contribs‎ 83,811 bytes +12‎ →‎Facilitated PCI trials using Abciximab
• curprev 14:4414:44, 30 January 2013‎ Raviteja Reddy Guddeti talk contribs‎ 83,799 bytes +12‎ →‎Facilitated PCI trials using Eptifibatide
• curprev 14:3814:38, 30 January 2013‎ Raviteja Reddy Guddeti talk contribs‎ 83,787 bytes +8‎ →‎Facilitated PCI trials using Eptifibatide
• curprev 14:0014:00, 30 January 2013‎ Raviteja Reddy Guddeti talk contribs‎ 83,779 bytes +8‎ →‎Facilitated PCI Trials Combining Low Dose Fibrinolytic Agent and Glycoprotein IIb/IIIa Inhibitor
• curprev 13:5113:51, 30 January 2013‎ Raviteja Reddy Guddeti talk contribs‎ 83,771 bytes +58‎ →‎Facilitated PCI Trials Combining Low Dose Fibrinolytic Agent and Glycoprotein IIb/IIIa Inhibitor
• curprev 13:4713:47, 30 January 2013‎ Raviteja Reddy Guddeti talk contribs‎ 83,713 bytes −1‎ →‎Use of Glycoprotein IIb/IIIa Inhibitors in Rescue PCI Following Failed Fibrinolysis
• curprev 13:4613:46, 30 January 2013‎ Raviteja Reddy Guddeti talk contribs‎ 83,714 bytes +8‎ →‎Use of Glycoprotein IIb/IIIa Inhibitors in Rescue PCI Following Failed Fibrinolysis
• curprev 13:4413:44, 30 January 2013‎ Raviteja Reddy Guddeti talk contribs‎ 83,706 bytes +4‎ →‎Use of Glycoprotein IIb/IIIa Inhibitors in Rescue PCI Following Failed Fibrinolysis
• curprev 13:4313:43, 30 January 2013‎ Raviteja Reddy Guddeti talk contribs‎ 83,702 bytes +4‎ →‎Use of Glycoprotein IIb/IIIa Inhibitors in Rescue PCI Following Failed Fibrinolysis

29 January 2013

• curprev 17:3017:30, 29 January 2013‎ Raviteja Reddy Guddeti talk contribs‎ 83,698 bytes +12‎ →‎Thrombocytopenia
• curprev 17:2917:29, 29 January 2013‎ Raviteja Reddy Guddeti talk contribs‎ 83,686 bytes +4‎ →‎Thrombocytopenia
• curprev 17:2817:28, 29 January 2013‎ Raviteja Reddy Guddeti talk contribs‎ 83,682 bytes 0‎ No edit summary
• curprev 16:3516:35, 29 January 2013‎ Raviteja Reddy Guddeti talk contribs‎ 83,682 bytes −3‎ /* Combination Therapy With Glycoprotein IIb/IIIa Inhibitors (DO NOT EDIT) {{cite journal| author=Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M et al.| title=ACC/AHA guidelines for the management of patients with ST-elevation myocar...
• curprev 16:3416:34, 29 January 2013‎ Raviteja Reddy Guddeti talk contribs‎ 83,685 bytes −3‎ /* 2013 Revised, 2009 and 2004 ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction and 2011 ACCF/AHA/SCAI Guidelines for Percutaneous Coronary Intervention, (DO NOT EDIT){{cite journal |author=O'Gara PT, Kus...
• curprev 16:3416:34, 29 January 2013‎ Raviteja Reddy Guddeti talk contribs‎ 83,688 bytes −3‎ →‎Sources

28 January 2013

• curprev 21:5221:52, 28 January 2013‎ Raviteja Reddy Guddeti talk contribs‎ 83,691 bytes +4‎ →‎Facilitated PCI trials using Eptifibatide
• curprev 21:5221:52, 28 January 2013‎ Raviteja Reddy Guddeti talk contribs‎ 83,687 bytes +4‎ →‎Facilitated PCI trials using Eptifibatide
• curprev 21:4621:46, 28 January 2013‎ Raviteja Reddy Guddeti talk contribs‎ 83,683 bytes +4‎ →‎Facilitated PCI trials using Abciximab
• curprev 21:4021:40, 28 January 2013‎ Raviteja Reddy Guddeti talk contribs‎ 83,679 bytes +12‎ →‎Facilitated PCI trials using Tirofiban
• curprev 21:3421:34, 28 January 2013‎ Raviteja Reddy Guddeti talk contribs‎ 83,667 bytes +4‎ →‎Comparisons of Glycoprotein IIb/IIIa Inhibitors
• curprev 21:3121:31, 28 January 2013‎ Raviteja Reddy Guddeti talk contribs‎ 83,663 bytes +25‎ →‎Comparisons of Glycoprotein IIb/IIIa Inhibitors
• curprev 21:2621:26, 28 January 2013‎ Raviteja Reddy Guddeti talk contribs‎ 83,638 bytes +1‎ →‎Facilitated PCI Using a Glycoprotein IIb/IIIa Inhibitor Alone in the Absence of Fibrinolytic Administration
• curprev 21:2421:24, 28 January 2013‎ Raviteja Reddy Guddeti talk contribs‎ 83,637 bytes +11‎ →‎Glycoprotein IIB/IIIA Inhibition
• curprev 21:2121:21, 28 January 2013‎ Raviteja Reddy Guddeti talk contribs‎ 83,626 bytes +12‎ →‎Other Antiplatelet Agents Including Aspirin and Thienopyridines
• curprev 21:1921:19, 28 January 2013‎ Raviteja Reddy Guddeti talk contribs‎ 83,614 bytes +10‎ No edit summary
• curprev 21:1521:15, 28 January 2013‎ Raviteja Reddy Guddeti talk contribs‎ 83,604 bytes +16‎ →‎Other Antiplatelet Agents Including Aspirin and Thienopyridines
• curprev 21:1021:10, 28 January 2013‎ Raviteja Reddy Guddeti talk contribs‎ 83,588 bytes −16‎ →‎Other Antiplatelet Agents Including Aspirin and Thienopyridines

1 January 2013

• curprev 23:5023:50, 1 January 2013‎ Raviteja Reddy Guddeti talk contribs‎ 83,604 bytes +9‎ →‎Glycoprotein IIB/IIIA Inhibition
• curprev 23:4923:49, 1 January 2013‎ Raviteja Reddy Guddeti talk contribs‎ 83,595 bytes +1,653‎ No edit summary

22 December 2012

• curprev 18:2218:22, 22 December 2012‎ Raviteja Reddy Guddeti talk contribs‎ 81,942 bytes +4‎ /* Combination Therapy With Glycoprotein IIb/IIIa Inhibitors (DO NOT EDIT) {{cite journal| author=Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M et al.| title=ACC/AHA guidelines for the management of patients with ST-elevation myocar...

20 December 2012

• curprev 21:2221:22, 20 December 2012‎ Raviteja Reddy Guddeti talk contribs‎ 81,938 bytes +1‎ →‎Mechanism of Benefit of Glycoprotein IIBIIIA Inhibition
• curprev 21:2121:21, 20 December 2012‎ Raviteja Reddy Guddeti talk contribs‎ 81,937 bytes +1‎ →‎Glycoprotein IIBIIIA Inhibition
• curprev 21:2021:20, 20 December 2012‎ Raviteja Reddy Guddeti talk contribs‎ 81,936 bytes +931‎ /* 2011 ACCF/AHA/SCAI Guidelines for Percutaneous Coronary Intervention, 2009 and 2004 ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (DO NOT EDIT){{cite journal |author=Levine GN, Bates ER, Blankenship ...
• curprev 21:1921:19, 20 December 2012‎ Raviteja Reddy Guddeti talk contribs‎ 81,005 bytes +2,531‎ /* Glycoprotein IIb/IIIa Inhibitors (DO NOT EDIT){{cite journal| author=Kushner FG, Hand M, Smith SC, King SB, Anderson JL, Antman EM et al.| title=2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardia...

12 November 2012

• curprev 18:4718:47, 12 November 2012‎ Kalsang Dolma talk contribs‎ 78,474 bytes 0‎ /* Glycoprotein IIb/IIIa Inhibitors (DO NOT EDIT){{cite journal| author=Kushner FG, Hand M, Smith SC, King SB, Anderson JL, Antman EM et al.| title=2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardia...

5 November 2012

• curprev 17:3817:38, 5 November 2012‎ Michael Maddaleni talk contribs‎ 78,474 bytes +12‎ /* Glycoprotein IIb/IIIa Inhibitors (DO NOT EDIT){{cite journal| author=Kushner FG, Hand M, Smith SC, King SB, Anderson JL, Antman EM et al.| title=2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardia...
• curprev 17:3517:35, 5 November 2012‎ Michael Maddaleni talk contribs‎ 78,462 bytes +25‎ /* 2011 ACCF/AHA/SCAI Guidelines for Percutaneous Coronary Intervention, 2009 and 2004 ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (DO NOT EDIT){{cite journal |author=Levine GN, Bates ER, Blankenship ...
• curprev 17:2417:24, 5 November 2012‎ Kalsang Dolma talk contribs‎ 78,437 bytes −268‎ /* Intravenous Antiplatelet Therapy in patients of ST-Elevation Myocardial Infarction (STEMI) (DO NOT EDIT){{cite journal |author=Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, ...
• curprev 17:1517:15, 5 November 2012‎ Kalsang Dolma talk contribs‎ 78,705 bytes +2,274‎ No edit summary

26 October 2012

• curprev 17:0317:03, 26 October 2012‎ Michael Maddaleni talk contribs‎ 76,431 bytes +193‎ /* 2009 ACC / AHA Guidelines- Combination Therapy With Glycoprotein IIb/IIIa Inhibitors (DO NOT EDIT){{cite journal |author=Antman EM, Anbe DT, Armstrong PW, et al |title=ACC/AHA guidelines for the management of patients with ST-elevation myocardi...
• curprev 17:0117:01, 26 October 2012‎ Michael Maddaleni talk contribs‎ 76,238 bytes +263‎ /* 2009 ACC / AHA Guidelines- Glycoprotein IIb/IIIa Inhibitors (DO NOT EDIT){{cite journal |author=Antman EM, Anbe DT, Armstrong PW, et al |title=ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive ...

19 October 2012

• curprev 19:0419:04, 19 October 2012‎ Shankar Kumar talk contribs‎ 75,975 bytes −201‎ /* 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Ang...

10 October 2012

• curprev 13:5113:51, 10 October 2012‎ Shankar Kumar talk contribs‎ 76,176 bytes +3‎ /* 2009 ACC / AHA Guidelines- Glycoprotein IIb/IIIa Inhibitors (DO NOT EDIT){{cite journal |author=Antman EM, Anbe DT, Armstrong PW, et al |title=ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive ...